Drug Type Small molecule drug |
Synonyms Compound 28g |
Target |
Action inhibitors |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), SEH1L inhibitors(SEH1 like nucleoporin inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H32ClF2N5O5 |
InChIKeyHBFPWUNFDONPPC-SFHVURJKSA-N |
CAS Registry3009011-58-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | China | 21 Jul 2024 |